Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Clinical trial NCT01587079 · COMPLETED
Trial details
- NCT number
- NCT01587079
- Sponsor
- Pearl Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2012-09-01
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.